Bioeq is a biopharmaceutical joint venture that focuses on the development, licensing, and commercialization of biosimilars. This company is backed by Polpharma Biologics Group and Formycon. Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference product.